Measles in the Americas: Questions and Answers – Technical Reference for Journalists and the Public

child with measles

What has happened to measles elimination in the Americas?

1. Has the Americas lost its measles elimination status?

Yes, the Region of the Americas lost its verification as free from endemic measles transmission in November 2025, following the re-establishment of endemic transmission in Canada.

The decision was announced by PAHO on 10 November 2025, following a review by the independent Measles and Rubella Elimination Regional Monitoring and Re-Verification Commission (RVC). The Commission concluded that the same measles virus genotype and lineage had circulated uninterrupted in Canada for at least 12 months.

The Americas first eliminated measles in 2016 and regained its regional elimination status in 2024. It was the first and remains the only WHO region to have achieved regional measles elimination, and the only one to have achieved it twice.

The loss of regional verification does not mean that every country in the Americas has lost its national elimination status. At the time of the November 2025 decision, Canada was the only country in the Region where endemic transmission had been re-established.

2. Which additional countries have now lost their measles elimination status?

The RVC reviewed the epidemiological and laboratory evidence for measles in all 47 reporting countries and territories of the Americas at its sixth annual meeting, held from 10 to 13 November 2026. 

After reviewing the data for the United States, Mexico, and Bolivia, the Commission concluded that all three countries had lost their verification status as free from endemic measles transmission, as the virus had circulated continuously in each country for at least 12 months, indicating that endemic transmission had been re-established. 

The PAHO Director, Dr. Jarbas Barbosa, received and agreed with the Commission's report, and communicated the change of status to each country's health authority.

The relevant periods of sustained transmission are:

  • United States: outbreak began on 20 January 2025; the 12-month threshold was reached on 20 January 2026.
  • Mexico: outbreak began on 1 February 2025; the 12-month threshold was reached on 1 February 2026.
  • Bolivia: outbreak began on 16 April 2025; the 12-month threshold was reached on 16 April 2026.

The loss of national elimination status does not mean that all parts of these countries are experiencing outbreaks. It means that the virus has circulated continuously for at least a 12-month period within that country.

3. What does it mean when a country loses its measles elimination status?

It means that measles is no longer considered to have been eliminated in that country because the virus has become established in sustained local transmission.

It does not mean that the country has lost all capacity to control the disease or that all areas of the country are experiencing outbreaks.

It means that epidemiological and laboratory evidence demonstrates that the virus has circulated continuously for at least 12 months, meeting the criteria for the re-establishment of endemic transmission.

This is a significant public health setback because it means the virus has circulated for a prolonged period, putting families and communities at risk of preventable illness, hospitalization and death.

4. How does a country lose its measles elimination status?

Under the regional verification framework, endemic transmission is considered to have been re-established when epidemiological and laboratory evidence indicates the presence of a chain of transmission of a virus strain (same genotype and lineage) that continues uninterrupted for ≥ 12 months in a defined geographical area.

Genotyping and sequencing are important because they help establish whether cases are linked to a continuing transmission chain or represent separate introductions of the virus. However, they alone cannot determine the source of infection, as the same genotype and lineage may circulate in multiple countries. High-quality epidemiological investigation is essential.

5. Does an imported measles case mean a country loses its elimination status?

No. Imported cases are expected because measles continues to circulate in many parts of the world.

A country can experience imported cases and even outbreaks without losing its elimination status, provided it successfully interrupts transmission before 12 months have elapsed since the rash onset date of the first confirmed case in the transmission chain.

Given the highly infectious nature of measles and the tendency of unvaccinated individuals to cluster in certain communities, countries must maintain strong surveillance and respond rapidly to every suspected case, even when measles is relatively uncommon.

6. What happened in Canada, and has the country now stopped transmission?

Canada's outbreak began in October 2024 and spread across multiple provinces, resulting in more than 12 months of continuous transmission. This led to the loss of Canada's national measles elimination status and, subsequently, the loss of the Region's verification as free from endemic measles transmission in November 2025.

Canadian federal, provincial and territorial health authorities have since worked to control the outbreak and interrupt the transmission chain responsible for the loss of status.

Even though the outbreak has now been successfully stopped, this does not automatically restore Canada's elimination status. Canada must demonstrate that transmission of the measles strain associated with the outbreak has been interrupted for at least 12 consecutive months and provide the necessary evidence for re-verification.

Canada's response has included:

  • Strengthening case detection and rapid epidemiological investigation.
  • Increasing laboratory testing and genomic surveillance.
  • Expanding vaccination activities, including temporary clinics in affected communities.
  • Working with community leaders and local organizations to improve vaccine access and acceptance.

The country has successfully prevented transmission to the general population, continues to monitor cases associated with new importations, and is working towards regaining its measles elimination status.

7. How does a country regain its measles elimination status?

A country must demonstrate that it has interrupted endemic transmission for at least 12 consecutive months.

It must also provide evidence that it has strengthened the systems needed to prevent transmission from becoming established again. This includes:

  • Achieving and maintaining high and homogenous vaccination coverage.
  • Strengthening epidemiological and laboratory surveillance.
  • Improving the capacity to detect and investigate suspected cases.
  • Ensuring rapid and effective outbreak response.
  • Implementing a corrective action plan aligned with the regional elimination framework.

The country submits evidence of its progress to the RVC, which reviews the information and makes a recommendation to the PAHO Director. The Director formally communicates the country's elimination classification.

Brazil provides an example. The country lost measles elimination status in 2019 after endemic transmission was re-established. Following extensive vaccination, surveillance and outbreak response efforts, endemic transmission was interrupted in 2022 and Brazil regained its measles-free status in November 2024.

8. How can the Americas regain regional measles elimination status?

The Region must interrupt endemic measles transmission in every country.

Regional elimination is a collective achievement. If even one country has established endemic transmission, the Region cannot be verified as free of endemic measles transmission.

This means that Canada, the United States, Mexico and Bolivia must demonstrate that they have interrupted endemic transmission and meet the requirements for re-verification. Other countries currently experiencing outbreaks must also act swiftly to interrupt transmission before it becomes endemic, reaching the 12-month threshold. 

Once the necessary evidence has been submitted and reviewed, the RVC can recommend re-verification of regional elimination status to the PAHO Director.

The Americas has demonstrated that this is possible. It regained regional elimination status in 2024 following the successful interruption of transmission in Brazil and Venezuela and the re-verification of the country's elimination status.

9. Why is it so difficult to eliminate measles while the virus is still circulating in other parts of the world?

Measles is one of the most contagious infectious diseases known. Without immunity or prevention measures, each case infects an average of 12-18 others. 

As long as measles continues to circulate in other parts of the world, countries that have eliminated the disease remain vulnerable to imported infections through international travel and population movements.

Importation alone does not mean elimination has been lost. However, when the virus enters a community with insufficient immunity, it can spread rapidly and establish sustained transmission.

This makes maintaining elimination particularly challenging. Countries must not only stop existing outbreaks but also continuously protect their populations against new introductions.

The Americas is the only WHO region to have achieved regional measles elimination. It first achieved this milestone in 2016 and regained it in 2024, making it the only WHO region to have achieved elimination twice.

Its experience demonstrates both that measles elimination is achievable and that it requires continuous investment and vigilance.

10. Have other countries outside the Americas lost their measles elimination status in 2026?

Yes. In January 2026, WHO announced that six countries in the European Region had lost their measles elimination status: Armenia, Austria, Azerbaijan, Spain, the United Kingdom and Uzbekistan.

The decisions were made by the European Regional Verification Commission in September 2025, based on epidemiological data from 2024, which demonstrated that endemic measles transmission had been re-established in these countries.

This highlights that the resurgence of measles is a global challenge. However, it is important to distinguish between experiencing an outbreak and losing elimination status. Imported cases and even significant outbreaks do not automatically result in the loss of status. This requires evidence of re-established endemic transmission, assessed against the verification criteria.

The global measles situation

11. What is happening with measles globally?

Measles is resurging in many parts of the world, with outbreaks reported across all six WHO regions.

The disease remains particularly prevalent in parts of Africa, Asia and the Eastern Mediterranean, where vaccination coverage is insufficient and access to health services can be limited.

WHO estimated that approximately 95,000 people died from measles in 2024, most of them unvaccinated or under-vaccinated children under five.

Global vaccination coverage remains below the levels needed to prevent outbreaks. In 2025, approximately 84% of children received their first dose of measles vaccine and 77% received a complete vaccination course.

Although vaccination has prevented an estimated 59 million deaths worldwide from measles between 2000 and 2024 (6 million in the Americas), recent increases in transmission demonstrate how quickly progress can be undermined when immunization coverage falls.

12. Why are measles cases increasing globally?

The resurgence reflects several overlapping factors:

  • Declining vaccination coverage: Many countries have not maintained the high two-dose coverage needed to prevent outbreaks.
  • Accumulation of susceptible populations: Children who missed routine vaccinations during the COVID-19 pandemic and in subsequent years have created immunity gaps.
  • Unequal vaccination coverage: National averages can conceal communities or geographical areas where vaccination rates are substantially lower.
  • Vaccine hesitancy and misinformation: Concerns about vaccine safety and misinformation can reduce acceptance in some communities.
  • Barriers to accessing health services: Poverty, geographical isolation, migration, conflict and weak health infrastructure can prevent children from receiving routine vaccinations.
  • International travel and population movements: Increased movement of people allows measles to spread rapidly across borders, introducing the virus into communities where immunity is insufficient.

These factors reinforce one another. Even countries with relatively strong health systems can experience sustained transmission when pockets of susceptible people remain unprotected.

13. Why is measles so difficult to control once an outbreak begins?

Measles is among the most contagious infectious diseases. Without immunity or prevention measures, one infected person can transmit the virus to an average of 12-18 others, and approximately nine out of every 10 susceptible people exposed to the virus will become infected.

The virus spreads through the air when a susceptible person inhales infectious respiratory particles released by an infected person when coughing, sneezing, or talking. These tiny particles can remain suspended in the air and stay infectious for up to two hours.

An infected person can transmit measles from four days before the rash appears until four days afterwards. This makes early detection and isolation challenging, as transmission can occur before the disease is recognized, limiting the effectiveness of isolation.

Outbreaks can therefore spread quickly, particularly in communities where vaccination coverage is low.

This is why rapid detection, investigation and vaccination response are essential. PAHO recommends initiating outbreak response measures within 72 hours of notification of a suspected case.

The situation in the Americas

14. How many measles cases and deaths have been reported in the Americas?

As of epidemiological week (EW) 44 (6 November 2026), 58,213 measles cases have been reported by member countries and territories. The highest proportion of cases has been reported among people aged 20–29 years, while the highest incidence has been observed in children under 1 year of age. A total of 114 deaths have been reported, most occurring among children under 5 years of age, although deaths have been recorded across all age groups.

15. Which countries are most affected?

In 2026, the highest number of cases have been reported in Guatemala (34,860 cases), Mexico (13,796 cases), United States (5,182), Perú (2,928 cases) and Canada (1,126).

16. Why has measles returned to the Americas after the Region successfully eliminated it twice?

The resurgence reflects a combination of declining population immunity, increased international travel and population movements, and the accumulation of unvaccinated or incompletely vaccinated people.

In 2025, regional routine vaccination coverage reached only 88% for the first dose of measles vaccine and 85% for the second dose, well below the 95% target.

Approximately 1.6 million one-year-old children in the Region had not received any measles vaccine, while another 400,000 had received only one dose.

These gaps are not distributed evenly. Some communities and geographical areas have substantially lower coverage than national averages suggest. Even relatively small clusters of susceptible people can sustain transmission and allow the virus to spread.

The resurgence demonstrates that elimination is not permanent. It requires continuous investment in vaccination, surveillance and outbreak response, even when cases become rare.

17. Why have some countries struggled to stop transmission, even when they have relatively strong health systems?

High national vaccination coverage is not enough if significant gaps remain in particular geographical areas or population groups.

Measles can spread rapidly within close-knit communities where vaccination coverage is low, potentially sustaining transmission for months before spreading to other populations.

Some communities also face barriers to accessing vaccination services, including geographical isolation, poverty, migration and limited access to health facilities. In others, vaccine hesitancy and misinformation contribute to low uptake.

Effective responses must therefore combine accessible vaccination services with community engagement, culturally appropriate communication and efforts to build confidence in vaccines.

Early detection is equally important. Countries that identify suspected cases quickly, investigate them thoroughly and organize targeted vaccination activities rapidly are more likely to interrupt transmission before it becomes established.

What needs to happen now?

18. What must countries do to stop measles transmission and regain elimination?

The path back to elimination is clear. Countries must strengthen three essential pillars:

  1. Vaccination: Achieve and sustain at least 95% coverage with two doses of measles-containing vaccine in every community, not simply at the national level. Catch-up campaigns are needed to reach children and other people who missed vaccinations.
  2. Surveillance: Strengthen epidemiological and laboratory surveillance to identify suspected cases early, investigate them thoroughly and monitor transmission chains, including through genetic sequencing.
  3. Rapid outbreak response: Respond immediately when cases are detected, including identifying and monitoring contacts, implementing targeted vaccination and taking measures to prevent further spread.

Countries experiencing sustained community transmission must rapidly scale up vaccination and strengthen clinical management and infection prevention and control to protect patients and health workers.

Importantly, response efforts must be maintained even when case numbers begin to decline. A downward trend does not necessarily mean that transmission has been interrupted.

19. What is PAHO doing to help countries control outbreaks and restore elimination?

PAHO is working directly with countries to strengthen vaccination programmes, improve surveillance and support outbreak response.

Its work includes:

  • Providing technical cooperation to national and subnational health authorities to strengthen outbreak control and elimination plans.
  • Supporting vaccination campaigns and helping countries identify and close immunity gaps.
  • Improving laboratory surveillance and genomic monitoring, including the reporting of viral sequences to WHO's Measles Nucleotide Surveillance (MeaNS) database.
  • Assessing outbreak response performance and identifying weaknesses in detection, investigation and containment.
  • Developing recommendations tailored to countries' respective epidemiological, healthcare and social situations.
  • Mobilizing financial and technical resources with international partners.

20. What can the public do to protect themselves and their communities?

Vaccination is the most effective way to prevent measles and stop its spread.

Everyone should check that they and their children have received the recommended two doses of measles-containing vaccine. Anyone whose vaccination status remains uncertain should consult their healthcare provider or local health authority and get vaccinated if their vaccination history cannot be confirmed.

People planning international travel to areas with active measles transmission should ensure they are fully vaccinated before departure. Infants aged 6–11 months should receive an additional early dose of measles-containing vaccine (zero dose), which does not count toward the routine vaccination schedule.

Anyone who develops symptoms suggestive of measles, particularly fever and rash, should seek medical advice and contact a healthcare provider or health facility before visiting in person to avoid exposing others to the virus.

Protecting against measles is a collective responsibility. High vaccination coverage in every community protects not only vaccinated individuals but also babies who are too young to be vaccinated and people who cannot receive vaccines for medical reasons.

21. Is the loss of elimination status permanent? 

No. Losing measles elimination status is a setback, but it is reversible.

The Americas has demonstrated that it is possible to regain elimination status through coordinated action, sustained political commitment, high vaccination coverage and strong surveillance and outbreak response. After endemic transmission was re-established in Venezuela and Brazil in 2018 and 2019, respectively, countries worked together to interrupt transmission, and the Region regained its measles elimination status in 2024.

The priority now is to interrupt transmission in affected countries, close the immunity gaps that allowed outbreaks to become established and ensure that the Region is better prepared to prevent future outbreaks.

Measles elimination is achievable, but it cannot be taken for granted. It must be maintained through continuous effort.

Latest epidemiological information

PAHO and WHO reference materials

The following links provide the principal source material for this Q&A. The latest epidemiological information should always be taken from the most recent PAHO situation report.

  1. PAHO urges countries to step up efforts to stop measles outbreaks and move towards elimination in the Americas.
  2. PAHO – Loss of regional measles elimination status (10 November 2025): PAHO calls for regional action as the Americas lose measles elimination status.
  3. PAHO – Regional Monitoring and Re-Verification Commission (RVC): Measles and Rubella Elimination Regional Monitoring and Re-Verification Commission. Includes the RVC's mandate, elimination criteria, re-verification process and examples of countries regaining status.
  4. PAHO – Update on the review of measles elimination status (2 March 2026): Update on the review of measles elimination status. Explains the review process, the 12-month criterion and the role of the RVC and PAHO Director.
  5. PAHO – Sixth annual RVC meeting (10–13 November 2026): Measles and Rubella Elimination Regional Monitoring and Re-Verification Commission to hold sixth annual meeting in November.
  6. PAHO – Latest measles situation reports: Measles multi-country outbreak: PAHO situation reports and documents. Includes the latest regional epidemiological reports. The most recent available at the time of drafting is: Situation Report No. 15: Measles in the Americas Region, 6 November 2026.
  7. PAHO – Measles and rubella surveillance bulletins: PAHO measles and rubella technical documents.
  8. Canada – Announcement that the multijurisdictional measles outbreak is over (19 October 2026): Public Health Agency of Canada: Multi-jurisdictional Measles Outbreak is Over. Confirms the end of the outbreak and explains that this does not automatically restore Canada's elimination status.
  9. WHO – Measles fact sheet: WHO: Measles. Includes global estimates, disease transmission, vaccination and prevention information.
  10. WHO – Immunization coverage: WHO: Immunization coverage. Includes global vaccination coverage estimates and information on children missing routine immunization.
  11. WHO – Global measles cases and incidence: WHO Immunization Data: Measles reported cases and incidence. Provides reported cases by year and region. Use with care, noting that global reported-case data are updated periodically and are not the same as estimated incidence.